A team of researchers, including a scientist from the Viral Immunology Center at Georgia State University, have found that a type of herpesvirus infection of the eye is associated with neovascular age-related macular degeneration (AMD), a disease that …
Author: The Medical News
Smartphones can improve QOL for people with poor vision
iPhones and other smartphones can be a huge help to the visually impaired, but few vision doctors are recommending them to patients, according to a study co-authored by a Loyola University Chicago Stritch School of Medicine ophthalmologist.
Mass. Eye and Ear announces recipients of 2012 Curing Kids Fund grants
The Mass. Eye and Ear Curing Kids fund has awarded grants for research projects that aim to help the brain locate sound, identify genes that cause congenital blindness, cure deafness through hair cell regeneration, and improve treatment for childhood e…
NSHC, NextGen Healthcare partner to deploy patient management solutions
NextGen Healthcare Information Systems, LLC, a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, today announced a new agreement with Norton Sound Health Corporation (N…
Genetic test can accurately predict spread of eye cancer
Researchers at Washington University School of Medicine in St. Louis have developed a genetic test that can accurately predict whether the most common form of eye cancer will spread to other parts of the body, particularly the liver.
Narrower CRAE may increase risk of CVD among African Americans with type 1 diabetes
Among African Americans with type 1 diabetes mellitus, narrower central retinal arteriolar equivalent (average diameter of the small arteries in the retina) is associated with an increased risk of six-year incidence of any cardiovascular disease and lo…
CooperVision to launch Proclear 1 day multifocal lenses
More than one billion people worldwide have a vision condition called presbyopia(1), which is a natural decrease in the ability of the lens in the eye to change its shape to focus on close objects. We’ve all seen others struggle with trying to read men…
Five-point checklist to protect eyes from sun’s harmful rays
Like your skin, overexposure to the sun can wreak havoc on your eyes. Sun damage can cause severe conditions such as sunburn to the cornea, tissue growth on the surface of eyes that can block vision, skin cancer of the eyelids and may even contribute t…
New system may help restore vision in eye diseases
Using tiny solar-panel-like cells surgically placed underneath the retina, scientists at the Stanford University School of Medicine have devised a system that may someday restore sight to people who have lost vision because of certain types of degenera…
Human Gene Therapy highlights new advances in human retinal disease
Gene therapy strategies to prevent and treat inherited diseases of the retina that can cause blindness have progressed rapidly. Positive results in animal models of human retinal disease continue to emerge, as reported in several articles published in …
Bayer Yakuhin, Santen enter co-promotion agreement for EYLEA Injection in Japan
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer’s Japanese subsidiary, Bayer Yakuhin, Ltd., and Santen Pharmaceutical Co., Ltd. entered into a co-promotion agreement for EYLEA aflibercept) Injection in Japan.
Brief empathy training program improves resident physicians interactions with patients
Resident physicians’ participation in a brief training program designed to increase empathy with their patients produced significant improvement in how patients perceived their interactions with the residents.
Amakem presents key preclinical data on AMA0076 at ARVO meeting
Amakem NV, a kinase platform company focusing on ophthalmology, presented key preclinical data on its potent, locally active Rho Kinase (ROCK) inhibitor AMA0076 at the 2012 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting bein…
Metformin blocks uveitis in laboratory rats
University of Texas Medical Branch at Galveston researchers have discovered that a drug already prescribed to millions of people with diabetes could also have another important use: treating one of the world’s leading causes of blindness.
Repeating trinucleotide a strong predictor of Fuchs’ dystrophy
Mayo Clinic and University of Oregon researchers have confirmed that a genetic factor called a repeating trinucleotide is a strong predictor of an individual’s risk of developing the eye condition Fuchs’ dystrophy. The findings were being presented tod…
New data from Acucela’s ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy
Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ACU-4429 program were presented during a poster session at The Association for Res…
No functional difference in effects of Lucentis and Avastin on preventing vision loss
The one year results from a study into whether two drug treatments (Lucentis and Avastin), are equally effective in treating neovascular or wet age-related macular degeneration (wet AMD), have been reported today at an international research meeting in…
Oral nutriceutical restores vision to otherwise hopeless patients facing permanent loss
There may be new found hope for patients whose vision is threatened when medicine injected directly into the eyes fails to cause abnormal blood vessels to recede. While injectable drugs called angiogenesis (an-gee-oh-jen-esis) inhibitors are considered…
Bionic eye helps two blind men see for the first time in 20 years
In a medical breakthrough two blind men have regained partial sight for the first time in more than 20 years after receiving a “bionic eye”. Scientists said the first clinical trials of the microchip eye implant, which measures just 3mm across and …
STAAR Surgical first quarter total revenue increases 4% to $15.5M
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported that sales of its Visian ICL product in the first quarter ended March 30, 2012 increased 25% to $8.6 million.